Kimberlee C Drapkin Net Worth & Insider Trades

Kimberlee C Drapkin - CFO and Treasurer, Jounce Therapeutics, Inc

As of February 3, 2022

What is Kimberlee C Drapkin's Net Worth?

The current estimated net worth of Jounce Therapeutics, Inc's CFO and Treasurer, Kimberlee C Drapkin, is estimated to be about $975.09K . Kimberlee C Drapkin owns about 52,614 units of Jounce Therapeutics, Inc common stock. In the last 4 years at Jounce Therapeutics, Inc, Kimberlee C Drapkin has sold an estimated value of $567.2K worth.

What is Kimberlee C Drapkin's Past Insider Trading?

Kimberlee C Drapkin's largest purchase order was 17,300 units , worth over $24.18K on January 22, 2021. Kimberlee C Drapkin's largest sale order was 30,000 units , worth over $340.79K on January 22, 2021. In total, Kimberlee C Drapkin has made about 11 transactions over 4 years of their time at Jounce Therapeutics, Inc. Kimberlee C Drapkin usually trades in January, with the busiest year in 2020. The most recent transaction was a sale order of 12,817 units , worth over $88.22K on January 11, 2022.

Kimberlee C Drapkin

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Kimberlee C Drapkin's' Mailing Address?

  • Mailing address is Predix Pharmaceuticals Holdings, Inc. 4 Maguire Road Lexington MA 02421 MA

Jounce Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Richard Murray, Ph.D., 2020 $565,100 $310,810 $491,316 $627,312 $8,946 $2,003,484
Richard Murray, Ph.D., 2019 $540,800 $295,500 $275,044 $348,665 $8,796 $1,468,805
Hugh M. Cole 2020 $420,000 $212,520 $196,500 $250,908 $8,808 $1,088,736
Hugh M. Cole 2019 $401,700 $153,700 $97,900 $124,115 $5,709 $783,124
Kim C. Drapkin 2020 $398,400 $175,300 $174,885 $223,308 $8,688 $980,581
Kim C. Drapkin 2019 $381,200 $145,800 $97,900 $124,115 $8,796 $757,811
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1640455/000164045521000078/jnce042621def14a.htm

What are Jounce Therapeutics, Inc's Past Insider Trades?

Jounce Therapeutics, Inc's most recent insider trade came on January 11, 2022 by Elizabeth Trehu who sold 8,383 units worth $57.7K . In the last 5 years, insiders at Jounce Therapeutics, Inc have sold an estimated value of $42.43M and bought an estimated value of $10.7M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Elizabeth Trehu, Chief Medical Officer,  Kimberlee C Drapkin, CFO and Treasurer,  and Ca Richard Murray, CEO and President .

Jounce Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1